Feb 29 (Reuters) - Elixinol Wellness Ltd (EXL) :
- RECONFIRMS FY24 REVENUE GUIDANCE OF A$16M - A$20M AND EBITDA BREAKEVEN BY MID-FY24
- FY23 REVENUE OF A$8.3M, UP 17%
- FY ADJUSTED EBITDA LOSS OF A$4.6M VERSUS LOSS OF A$8.5M
News: EXL Elixinol Wellness Reconfirms FY24 Revenue Guidance Of A$16M - A$20M
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.323M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $33.97K | 2.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1474341 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 424238 | 3 |
View Market Depth
| Last trade - 10.51am 19/09/2025 (20 minute delay) ? |
| EXL (ASX) Chart |